HSA — authorised 29 September 2021
- Marketing authorisation holder: MIRUM PHARMA INC
- Status: likely_approved
🇸🇬 Livmarli in Singapore
HSA authorised Livmarli on 29 September 2021
Marketing authorisation
Livmarli in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Singapore
Frequently asked questions
Is Livmarli approved in Singapore?
Yes. HSA authorised it on 29 September 2021.
Who is the marketing authorisation holder for Livmarli in Singapore?
MIRUM PHARMA INC holds the Singaporean marketing authorisation.